Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria

Sarah O John-Olabode,1 Kehinde S Okunade,2 Ayorinde James,3 Gbenga Olorunfemi,4 Obiefuna I Ajie,5 Akinniyi A Osuntoki,6 Alani S Akanmu1 1Department of Hematology and Blood Transfusion, College of Medicine, University of Lagos, Lagos, Nigeria; 2Department of Obstetrics and Gynecology, College of Medi...

Full description

Bibliographic Details
Main Authors: John-Olabode SO, Okunade KS, James A, Olorunfemi G, Ajie OI, Osuntoki AA, Akanmu AS
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:Journal of Blood Medicine
Subjects:
Online Access:https://www.dovepress.com/prevalence-of-factor-v-leiden-g1691a-and-prothrombin-g20210a-gene-muta-peer-reviewed-fulltext-article-JBM
_version_ 1818655164582592512
author John-Olabode SO
Okunade KS
James A
Olorunfemi G
Ajie OI
Osuntoki AA
Akanmu AS
author_facet John-Olabode SO
Okunade KS
James A
Olorunfemi G
Ajie OI
Osuntoki AA
Akanmu AS
author_sort John-Olabode SO
collection DOAJ
description Sarah O John-Olabode,1 Kehinde S Okunade,2 Ayorinde James,3 Gbenga Olorunfemi,4 Obiefuna I Ajie,5 Akinniyi A Osuntoki,6 Alani S Akanmu1 1Department of Hematology and Blood Transfusion, College of Medicine, University of Lagos, Lagos, Nigeria; 2Department of Obstetrics and Gynecology, College of Medicine, University of Lagos, Lagos, Nigeria; 3Department of Biochemistry and Nutrition, Nigerian Institute of Medical Research, Lagos, Nigeria; 4Division of Epidemiology and Biostatistics, School of Public Health, University of Witwatersrand, Johannesburg, South Africa; 5Department of Clinical Pathology, College of Medicine, University of Lagos, Lagos, Nigeria; 6Department of Biochemistry, College of Medicine, University of Lagos, Lagos, NigeriaCorrespondence: Sarah O John-OlabodeDepartment of Hematology and Blood Transfusion, College of Medicine, University of Lagos, Lagos, NigeriaTel +234 8096608152Email sarahajibola@yahoo.comIntroduction: Inherited thrombophilia and venous thromboembolism (VTE) have been closely linked to adverse pregnancy outcomes such as preeclampsia/eclampsia contributing to increased maternal and perinatal morbidity and mortality. There is, however, little genetic data from Africa including Nigeria that explores the prevalence of common VTE genetic risk markers such as factor V Leiden mutation (FVL G1691A) and prothrombin gene mutation (F2 G20210A) among pregnant women in Nigeria.Purpose: To determine the prevalence and distribution of FVL G1691A and F2 G20210A in pregnant women in Lagos, Nigeria.Patients and Methods: This hospital-based cross-sectional pilot study was conducted among pregnant women between 1 July 2019 and 31 August 2020. The genotype of interest was determined through amplification by polymerase chain reaction using G1691A of FV and prothrombin A20210G specific primers. Descriptive data were presented using Stata version 15 (Stata Corp) statistical software.Results: Of the 400 recruited participants, 397 and 389 samples were successfully processed for FVL G1691A and F2 G20210A mutations, respectively. Three participants had FVL heterozygous mutation; thus, the prevalence of heterozygous mutation of FVL among the study participants was 0.76%, 95% CI: 0.002– 0.023%, n=3/397. There was no F2 G20210A mutation detected among the study participants.Conclusion: This study indicates that screening for factor V Leiden mutation and prothrombin gene mutation in pregnancy might not be of any clinical significance among Nigerian women. However, carrying out a genome-wide associated study is recommended to determine the true impact of these two common inherited thrombophilias in this population.Keywords: factor V Leiden G1691A, prothrombin G20210A gene mutation, factor 2, factor V, preeclampsia, venous thromboembolism
first_indexed 2024-12-17T03:05:20Z
format Article
id doaj.art-f0f97efe00c4450a963173165634b538
institution Directory Open Access Journal
issn 1179-2736
language English
last_indexed 2024-12-17T03:05:20Z
publishDate 2021-05-01
publisher Dove Medical Press
record_format Article
series Journal of Blood Medicine
spelling doaj.art-f0f97efe00c4450a963173165634b5382022-12-21T22:05:58ZengDove Medical PressJournal of Blood Medicine1179-27362021-05-01Volume 1230731264909Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in NigeriaJohn-Olabode SOOkunade KSJames AOlorunfemi GAjie OIOsuntoki AAAkanmu ASSarah O John-Olabode,1 Kehinde S Okunade,2 Ayorinde James,3 Gbenga Olorunfemi,4 Obiefuna I Ajie,5 Akinniyi A Osuntoki,6 Alani S Akanmu1 1Department of Hematology and Blood Transfusion, College of Medicine, University of Lagos, Lagos, Nigeria; 2Department of Obstetrics and Gynecology, College of Medicine, University of Lagos, Lagos, Nigeria; 3Department of Biochemistry and Nutrition, Nigerian Institute of Medical Research, Lagos, Nigeria; 4Division of Epidemiology and Biostatistics, School of Public Health, University of Witwatersrand, Johannesburg, South Africa; 5Department of Clinical Pathology, College of Medicine, University of Lagos, Lagos, Nigeria; 6Department of Biochemistry, College of Medicine, University of Lagos, Lagos, NigeriaCorrespondence: Sarah O John-OlabodeDepartment of Hematology and Blood Transfusion, College of Medicine, University of Lagos, Lagos, NigeriaTel +234 8096608152Email sarahajibola@yahoo.comIntroduction: Inherited thrombophilia and venous thromboembolism (VTE) have been closely linked to adverse pregnancy outcomes such as preeclampsia/eclampsia contributing to increased maternal and perinatal morbidity and mortality. There is, however, little genetic data from Africa including Nigeria that explores the prevalence of common VTE genetic risk markers such as factor V Leiden mutation (FVL G1691A) and prothrombin gene mutation (F2 G20210A) among pregnant women in Nigeria.Purpose: To determine the prevalence and distribution of FVL G1691A and F2 G20210A in pregnant women in Lagos, Nigeria.Patients and Methods: This hospital-based cross-sectional pilot study was conducted among pregnant women between 1 July 2019 and 31 August 2020. The genotype of interest was determined through amplification by polymerase chain reaction using G1691A of FV and prothrombin A20210G specific primers. Descriptive data were presented using Stata version 15 (Stata Corp) statistical software.Results: Of the 400 recruited participants, 397 and 389 samples were successfully processed for FVL G1691A and F2 G20210A mutations, respectively. Three participants had FVL heterozygous mutation; thus, the prevalence of heterozygous mutation of FVL among the study participants was 0.76%, 95% CI: 0.002– 0.023%, n=3/397. There was no F2 G20210A mutation detected among the study participants.Conclusion: This study indicates that screening for factor V Leiden mutation and prothrombin gene mutation in pregnancy might not be of any clinical significance among Nigerian women. However, carrying out a genome-wide associated study is recommended to determine the true impact of these two common inherited thrombophilias in this population.Keywords: factor V Leiden G1691A, prothrombin G20210A gene mutation, factor 2, factor V, preeclampsia, venous thromboembolismhttps://www.dovepress.com/prevalence-of-factor-v-leiden-g1691a-and-prothrombin-g20210a-gene-muta-peer-reviewed-fulltext-article-JBMfactor v leiden g1691aprothrombin g20210a gene mutationfactor 2factor vpreeclampsiavenous thromboembolism
spellingShingle John-Olabode SO
Okunade KS
James A
Olorunfemi G
Ajie OI
Osuntoki AA
Akanmu AS
Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria
Journal of Blood Medicine
factor v leiden g1691a
prothrombin g20210a gene mutation
factor 2
factor v
preeclampsia
venous thromboembolism
title Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria
title_full Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria
title_fullStr Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria
title_full_unstemmed Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria
title_short Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria
title_sort prevalence of factor v leiden g1691a and prothrombin g20210a gene mutation among pregnant women experience from a multi center study in nigeria
topic factor v leiden g1691a
prothrombin g20210a gene mutation
factor 2
factor v
preeclampsia
venous thromboembolism
url https://www.dovepress.com/prevalence-of-factor-v-leiden-g1691a-and-prothrombin-g20210a-gene-muta-peer-reviewed-fulltext-article-JBM
work_keys_str_mv AT johnolabodeso prevalenceoffactorvleideng1691aandprothrombing20210agenemutationamongpregnantwomenexperiencefromamulticenterstudyinnigeria
AT okunadeks prevalenceoffactorvleideng1691aandprothrombing20210agenemutationamongpregnantwomenexperiencefromamulticenterstudyinnigeria
AT jamesa prevalenceoffactorvleideng1691aandprothrombing20210agenemutationamongpregnantwomenexperiencefromamulticenterstudyinnigeria
AT olorunfemig prevalenceoffactorvleideng1691aandprothrombing20210agenemutationamongpregnantwomenexperiencefromamulticenterstudyinnigeria
AT ajieoi prevalenceoffactorvleideng1691aandprothrombing20210agenemutationamongpregnantwomenexperiencefromamulticenterstudyinnigeria
AT osuntokiaa prevalenceoffactorvleideng1691aandprothrombing20210agenemutationamongpregnantwomenexperiencefromamulticenterstudyinnigeria
AT akanmuas prevalenceoffactorvleideng1691aandprothrombing20210agenemutationamongpregnantwomenexperiencefromamulticenterstudyinnigeria